Ghost Tree Capital, LLC Cyma Bay Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.63 - $24.47 $1.14 Million - $2.2 Million	90,000 New	90,000 $2.13 Million
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $585,200 - $2.61 Million	-440,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.12 - $7.21 $2.87 Million - $4.04 Million	-560,000 Reduced 56.0%	440,000 $2.25 Million
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $1.51 Million - $3.42 Million	250,000 Added 33.33%	1,000,000 $7.16 Million
Q1 2019 May 15, 2019	BUY	$8.16 - $13.42 $6.12 Million - $10.1 Million	750,000 New	750,000 $9.96 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.